28 abril 2015
The optimal window of time to stimulate heart muscle cell regeneration — cardiomyocyte proliferation — in humans is the first six months of life, researchers have discovered. The drug neuregulin is currently under investigation as a drug treatment for heart failure in adults, but corresponding studies for pediatric applications had not been attempted before now.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/eKPZaPXq92A/150428125426.htm
